It is a tremendous honor to support these founders’ journeys and to see the innovative solutions developed by our Vanderbilt community.” “We are actively supporting Vanderbilt and VUMC faculty, students and affiliates in bringing their ideas from the lab into the world. “Supporting research commercialization for ventures developed at Vanderbilt and VUMC is among our highest priorities as a world-class research institution,” Sweet said. They constitute the first wave of what the university intends to be continued support of Vanderbilt-initiated startups. Startups were proffered to the committee by leadership within the Center for Technology Transfer and Commercialization and the Wond’ry. Pietenpol is charged with reviewing and approving these investments. FUTURE INVESTMENTSĪ university leadership committee led by Vice Chancellor for Finance, Information Technology and Chief Financial Officer Brett Sweet, Vice Provost for Research and Innovation Padma Raghavan and VUMC Chief Scientific and Strategy Officer and Executive Vice President for Research Jennifer A.
DISCOVERY INC BENEFITS VERIFICATION
Virtuoso anticipates verification and validation testing to start this year. Virtuoso also has received research funds from federal and statewide sources, including Small Business Innovation Research and Small Business Technology Transfer programs and LaunchTN. School of Engineering alum Richard Hendrick, PhD’17, is chief operating officer. Herrell serves as Virtuoso chief executive officer, and Webster is chief technology officer. The company was founded in 2016, and the first prototype became operational in 2018. Schroeder Professor of Mechanical Engineering and associate professor of medicine and urology, and Duke Herrell, director of robotics at VUMC and professor of urology, biomedical and mechanical engineering. The robot was developed at the Vanderbilt Institute for Surgery and Engineering by Robert Webster, Richard A. Its flagship product is a minuscule robot with the potential to revolutionize surgical procedures treating prostate cancer, which affects one in nine men in the U.S. Virtuoso developed a robotic surgery system that enables physicians to overcome the limitations of traditional endoscopes. This month, HeroWear introduced its newest commercially available version of its back-assist exosuit. SABER is being prepared for manufacturing and commercialization by HeroWear and for field use by the Army. The funding supported the Army’s Pathfinder program, a collaboration between Vanderbilt and soldiers of the 101st Airborne Division to develop the Soldier Assistive Bionic Exosuit for Resupply, or SABER, a first-of-its-kind exosuit that supports soldiers participating in sustainment and logistics operations. In April 2021, Zelik received a one-year, $1.2 million investment from the Army Futures Command’s research lab, known as DEVCOM, and the Civil-Military Innovation Institute Inc.
HeroWear was established in 2019 Zelik serves as its chief scientific officer and co-founder. Their exosuit was developed in the Center for Rehabilitation Engineering and Assistive Technology by Karl Zelik, associate professor of mechanical engineering, biomedical engineering and physical medicine and rehabilitation. HeroWear develops wearable assist devices, called exosuits, to alleviate back strain and injuries-especially for those who do heavy and repetitive lifting.
“Funding groundbreaking faculty-led startups like HeroWear, IDBiologics and Virtuoso is central to the purpose of Discovery Vanderbilt and allows us to extend the impact of our research and innovation locally, nationally and globally,” Provost and Vice Chancellor for Academic Affairs C. The investments were provided by Discovery Vanderbilt, which is sponsored by the offices of the chancellor and provost and led by the Office of the Provost.
DISCOVERY INC BENEFITS SERIES
HeroWear received seed funding of $250,000, and IDBiologics and Virtuoso received seed and Series A funding of $500,000, respectively. “I look forward to the innovations that will grow from these partnerships, and to future investments by the committee that are sure to push new ideas into the frontiers of discovery while underscoring our continued service to others and community.” “These three initial investments will fuel discovery and accelerate the translation of our research into real-world benefits,” Chancellor Daniel Diermeier said.
0 kommentar(er)
